$NYMX NYMOX PHARMACEUTICAL CORP Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NYMOX PHARMACEUTICAL CORP.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NYMOX PHARMACEUTICAL CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in NYMOX PHARMACEUTICAL CORP for free.

CIK Number: 0001018735
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: NYMX
Company Address: 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA H4M 2V2

Nymox Pharmaceutical Corp.operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.

Market Capitalization: $174.27M
Prev close: $3.78
Average Daily Volume: 175,555
Days Low: $3.60
Year Low: $1.62
Year High: $5.79

NYMOX PHARMACEUTICAL CORP Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 27 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.941003943,160,5503.2 M to 3.2 M (0.00 %)
Mar 27 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.939003,5373,160,4503.2 M to 3.2 M (+0.03 %)
Mar 27 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.937,00027,5033,159,5503.2 M to 3.2 M (+0.22 %)
Mar 22 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP4.028,00032,1603,152,5503.1 M to 3.2 M (+0.25 %)
Mar 16 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.588,00028,6723,144,5503.1 M to 3.1 M (+0.26 %)
Mar 12 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.488,00027,8643,136,5503.1 M to 3.1 M (+0.26 %)
Feb 23 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.235,30017,1193,128,5503.1 M to 3.1 M (+0.17 %)
Feb 23 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.227002,2543,123,2503.1 M to 3.1 M (+0.02 %)
Feb 23 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.235,30017,1193,128,5503.1 M to 3.1 M (+0.17 %)
Feb 23 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.227002,2543,123,2503.1 M to 3.1 M (+0.02 %)
Feb 20 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.273,94112,8953,122,5503.1 M to 3.1 M (+0.13 %)
Feb 20 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.283,05910,0263,118,6093.1 M to 3.1 M (+0.10 %)
Feb 13 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.331,0003,3303,115,5503.1 M to 3.1 M (+0.03 %)
Feb 13 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.325001,6603,114,5503.1 M to 3.1 M (+0.02 %)
Feb 13 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.311003313,114,0503.1 M to 3.1 M (0.00 %)

View all NYMOX PHARMACEUTICAL CORP insider transactions.